Major strides for the company on two fronts – psychedelic therapies and treatment-resistant depression (TRD) – came in the ...

Scientists at the University of Pittsburgh have tested a broadly neutralizing antibody (bnAb) that binds the stem of a protein against H5N1 avian influenza, which prevented severe disease in nonhuman ...

Implanted patches of iPS cell-derived heart muscle integrated with heart tissue in a primate model of heart failure, and in ...

Harness Therapeutics Ltd. has raised fresh financing to further develop its technology for upregulating the translation of ...

Alterity Therapeutics Ltd. reported positive top-line phase II results for lead candidate ATH-434 for treating multiple ...

With multiple large M&A deals already announced in January, CEOs of major med-tech companies outlining acquisition plans for ...

Researchers from Fundación Jiménez Díaz and affiliated organizations have published data from a study that aimed to identify ...

A new guidance by the International Medical Device Regulators Forum for good machine learning practices draws heavily on a 2021 playbook provided by Canada, the U.K. and the U.S., an outcome that also ...

Harmonized regulations for laboratory-developed tests (LDTs) across Asia Pacific are sorely needed at a time when LDTs continue to play a critical role in addressing unmet needs in the region, ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...

In what represents the first PCT filing emerging in the name of Ayble Health Inc., protection is sought for a system for adaptive, multi-level processing of health data to be used in the ...